Back to funds

SILVERARC CAPITAL MANAGEMENT, LLC

hedge fundUpdated 10 days ago

Managed by Silverarc Capital Management, Llc • Latest filing Q3 2026

Portfolio value
$854.4M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
96.1%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$720.1M
Q1 2026$979.8M
Q2 2026$962.2M
Q3 2026$854.4M

Top holdings

70 positions as of Q3 2026

View filing
K

KODIAK SCIENCES INC

Value
$71.1M
Shares
750.2K
% Port
8.32%
C

CELCUITY INC

Value
$63.9M
Shares
803.2K
% Port
7.47%
C

COGENT BIOSCIENCES INC

Value
$50.4M
Shares
1.57M
% Port
5.90%
U

UROGEN PHARMA LTD

Value
$46.7M
Shares
1.15M
% Port
5.46%
I

IMMUNOME INC

Value
$45M
Shares
2.09M
% Port
5.27%
M

MONTE ROSA THERAPEUTICS INC

Value
$37.1M
Shares
3.11M
% Port
4.35%
S

SAGIMET BIOSCIENCES INC

Value
$37M
Shares
3.75M
% Port
4.33%
A

ASCENDIS PHARMA A/S

Value
$34.7M
Shares
152.2K
% Port
4.06%
R

RHYTHM PHARMACEUTICALS INC

Value
$33.2M
Shares
348.3K
% Port
3.88%
B

BIOGEN INC

Value
$25.5M
Shares
112.8K
% Port
2.98%
I

IMMUNOVANT INC

Value
$21.1M
Shares
624.1K
% Port
2.47%
D

DIANTHUS THERAPEUTICS INC

Value
$20.8M
Shares
236.6K
% Port
2.44%
O

ORUKA THERAPEUTICS INC

Value
$20.6M
Shares
247.9K
% Port
2.42%
E

ERASCA INC

Value
$19.5M
Shares
1.33M
% Port
2.28%
A

ABIVAX SA

Value
$17.4M
Shares
175.7K
% Port
2.04%
C

CELLDEX THERAPEUTICS INC NEW

Value
$15.8M
Shares
487.6K
% Port
1.85%
O

OVID THERAPEUTICS INC

Value
$14.8M
Shares
5.95M
% Port
1.73%
S

SPYRE THERAPEUTICS INC

Value
$13.5M
Shares
151.2K
% Port
1.57%
D

DEFINIUM THERAPEUTICS INC

Value
$13.2M
Shares
345.9K
% Port
1.54%
?
20.N/A

HELIX ACQUISITION CORP III

Value
$12.8M
Shares
1.21M
% Port
1.50%

Explore